Literature DB >> 12824484

A solution NMR study of the binding kinetics and the internal dynamics of an HIV-1 protease-substrate complex.

Etsuko Katoh1, John M Louis, Toshimasa Yamazaki, Angela M Gronenborn, Dennis A Torchia, Rieko Ishima.   

Abstract

NMR studies of the binding of a substrate to an inactive HIV-1 protease construct, containing an active site mutation PR(D25N), are reported. Substrate titration measurements monitored by HSQC spectra and a (15)N-edited NOESY experiment show that the chromogenic substrate analog of the capsid/p2 cleavage site binds to PR(D25N) with an equilibrium dissociation constant, K(D), of 0.27 +/- 0.05 mM, and upper limits of the association and dissociation rate constants, 2 x 10(4) M(-1)s(-1) and 10 s(-1), respectively, at 20 degrees C, pH 5.8. This association rate constant is not in the diffusion limit, suggesting that association is controlled by a rare event, such as opening of the protease flaps. Analysis of (15)N relaxation experiments reveals a slight reduction of S(2) values in the flap region, indicating a small increase in the amplitude of internal motion on the sub-nsec timescale. In addition, several residues in the flap region are mobile on the conformational exchange timescale, msec-microsec. Flap dynamics of the protease-substrate complex are compared with those of protease-inhibitor complexes, and the implications of these results for substrate-binding models are discussed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12824484      PMCID: PMC2323926          DOI: 10.1110/ps.0300703

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  27 in total

1.  Substrate shape determines specificity of recognition for HIV-1 protease: analysis of crystal structures of six substrate complexes.

Authors:  Moses Prabu-Jeyabalan; Ellen Nalivaika; Celia A Schiffer
Journal:  Structure       Date:  2002-03       Impact factor: 5.006

2.  Overcoming drug resistance in HIV-1 chemotherapy: the binding thermodynamics of Amprenavir and TMC-126 to wild-type and drug-resistant mutants of the HIV-1 protease.

Authors:  Hiroyasu Ohtaka; Adrian Velázquez-Campoy; Dong Xie; Ernesto Freire
Journal:  Protein Sci       Date:  2002-08       Impact factor: 6.725

Review 3.  Retroviral proteinases.

Authors:  S Oroszlan; R B Luftig
Journal:  Curr Top Microbiol Immunol       Date:  1990       Impact factor: 4.291

4.  Inhibitor binding to the Phe53Trp mutant of HIV-1 protease promotes conformational changes detectable by spectrofluorometry.

Authors:  E J Rodríguez; C Debouck; I C Deckman; H Abu-Soud; F M Raushel; T D Meek
Journal:  Biochemistry       Date:  1993-04-13       Impact factor: 3.162

Review 5.  Structure-based inhibitors of HIV-1 protease.

Authors:  A Wlodawer; J W Erickson
Journal:  Annu Rev Biochem       Date:  1993       Impact factor: 23.643

6.  A heteronuclear correlation experiment for simultaneous determination of 15N longitudinal decay and chemical exchange rates of systems in slow equilibrium.

Authors:  N A Farrow; O Zhang; J D Forman-Kay; L E Kay
Journal:  J Biomol NMR       Date:  1994-09       Impact factor: 2.835

7.  Rapid structural fluctuations of the free HIV protease flaps in solution: relationship to crystal structures and comparison with predictions of dynamics calculations.

Authors:  Darón I Freedberg; Rieko Ishima; Jaison Jacob; Yun-Xing Wang; Irina Kustanovich; John M Louis; Dennis A Torchia
Journal:  Protein Sci       Date:  2002-02       Impact factor: 6.725

8.  Curling of flap tips in HIV-1 protease as a mechanism for substrate entry and tolerance of drug resistance.

Authors:  W R Scott; C A Schiffer
Journal:  Structure       Date:  2000-12-15       Impact factor: 5.006

9.  How does a symmetric dimer recognize an asymmetric substrate? A substrate complex of HIV-1 protease.

Authors:  M Prabu-Jeyabalan; E Nalivaika; C A Schiffer
Journal:  J Mol Biol       Date:  2000-09-01       Impact factor: 5.469

10.  Two-step binding mechanism for HIV protease inhibitors.

Authors:  E S Furfine; E D'Souza; K J Ingold; J J Leban; T Spector; D J Porter
Journal:  Biochemistry       Date:  1992-09-01       Impact factor: 3.162

View more
  40 in total

1.  Intramolecular regulation of the sequence-specific mRNA interferase activity of MazF fused to a MazE fragment with a linker cleavable by specific proteases.

Authors:  Jung-Ho Park; Yoshihiro Yamaguchi; Masayori Inouye
Journal:  Appl Environ Microbiol       Date:  2012-03-23       Impact factor: 4.792

2.  Solution conformation and dynamics of the HIV-1 integrase core domain.

Authors:  Nicholas C Fitzkee; James E Masse; Yang Shen; David R Davies; Ad Bax
Journal:  J Biol Chem       Date:  2010-04-01       Impact factor: 5.157

3.  Spin labeling and Double Electron-Electron Resonance (DEER) to Deconstruct Conformational Ensembles of HIV Protease.

Authors:  Thomas M Casey; Gail E Fanucci
Journal:  Methods Enzymol       Date:  2015-09-01       Impact factor: 1.600

4.  Pulsed EPR characterization of HIV-1 protease conformational sampling and inhibitor-induced population shifts.

Authors:  Zhanglong Liu; Thomas M Casey; Mandy E Blackburn; Xi Huang; Linh Pham; Ian Mitchelle S de Vera; Jeffrey D Carter; Jamie L Kear-Scott; Angelo M Veloro; Luis Galiano; Gail E Fanucci
Journal:  Phys Chem Chem Phys       Date:  2016-02-17       Impact factor: 3.676

Review 5.  Characterization of the fast dynamics of protein amino acid side chains using NMR relaxation in solution.

Authors:  Tatyana I Igumenova; Kendra King Frederick; A Joshua Wand
Journal:  Chem Rev       Date:  2006-05       Impact factor: 60.622

6.  HIV-1 protease flaps spontaneously open and reclose in molecular dynamics simulations.

Authors:  Viktor Hornak; Asim Okur; Robert C Rizzo; Carlos Simmerling
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-17       Impact factor: 11.205

Review 7.  Targeting structural flexibility in HIV-1 protease inhibitor binding.

Authors:  Viktor Hornak; Carlos Simmerling
Journal:  Drug Discov Today       Date:  2006-12-20       Impact factor: 7.851

8.  Gated binding of ligands to HIV-1 protease: Brownian dynamics simulations in a coarse-grained model.

Authors:  Chia-En Chang; Tongye Shen; Joanna Trylska; Valentina Tozzini; J Andrew McCammon
Journal:  Biophys J       Date:  2006-03-13       Impact factor: 4.033

9.  Interactions of different inhibitors with active-site aspartyl residues of HIV-1 protease and possible relevance to pepsin.

Authors:  Jane M Sayer; John M Louis
Journal:  Proteins       Date:  2009-05-15

10.  A poke in the eye: inhibiting HIV-1 protease through its flap-recognition pocket.

Authors:  Kelly L Damm; Peter M U Ung; Jerome J Quintero; Jason E Gestwicki; Heather A Carlson
Journal:  Biopolymers       Date:  2008-08       Impact factor: 2.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.